Ghrelin Arg51Gln mutation is a risk factor for Type 2 diabetes and hypertension in a random sample of middle-aged subjects

Diabetologia

Volumn 46, Issue 4, 2003, Pages 455-458

  Poykko S ^a   Ukkola, O ^a   Kauma, H ^a   Savolainen, M J ^a   Kesaniemi Y A ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Ghrelin; Hypertension; IGF I; Mutation; Risk factors; Type 2 diabetes

Indexed keywords

ARGININE; DNA FRAGMENT; GHRELIN; GLUCOSE; GLUTAMINE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; MUTANT PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C; TRIACYLGLYCEROL;

ADULT; AGE; ALLELE; ARTICLE; BLOOD PRESSURE; BODY MASS; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RISK FACTOR;

EID: 0037955956     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-003-1058-z     Document Type: Article

References (11)

1. Arvat E, Di Vito L, Broglio F et al. (2000) Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. J Endocrinol Invest 23:493-495
2. Ukkola O, Pöykkö S (2002) Ghrelin, growth and obesity. Ann Med 34:102-108
3. Broglio F, Arvat E, Benso A et al. (2001) Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab 86:5083-5086
4. Nagaya N, Kojima M, Uematsu M et al. (2001) Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regul Integr Comp Physiol 280:R1483-R1487
5. Ukkola O, Ravussin E, Jacobson P et al. (2001) Mutations in the preproghrelin/ghrelin gene associated with obesity in humans. J Clin Endocrinol Metab 86:3996-3999
6. Ukkola O, Ravussin E, Jacobson P et al. (2002) Role of ghrelin polymorphisms in obesity based on three different studies. Obes Res 10:782-791
7. Kiema TR, Kauma H, Rantala AO et al. (1996) Variation at the angiotensin-converting enzyme gene and angiotensinogen gene loci in relation to blood pressure. Hypertension 28:1070-1075
8. Le Roith D, Scavo L, Butler A (2001) What is the role of circulating IGF-I? Trends Endocrinol Metab 12:48-52
9. Shiiya T, Nakazato M, Mizuta M et al. (2002) Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 87:240-244
10. Date Y, Nakazato M, Hashiguchi S et al. (2002) Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion. Diabetes 51:124-129
11. Boger RH, Skamira C, Bode-Boger SM, Brabant G, von Zur MA, Frolich JC (1996) Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study. J Clin Invest 98:2706-2713